In non-small cell lung cancer and prostate cancer, CUL4B is confirmed as a functional target of miR-101, and its knockdown results in a strong alleviation of cell proliferation, which is enhanced by the silencing of miR-101 [47,48]. Here, CUL4B is linked to non-small cell lung carcinoma.